Anticoagulation in COVID-19: current concepts and controversies

A Chandra, U Chakraborty, S Ghosh… - Postgraduate Medical …, 2022 - academic.oup.com
Rising incidence of thromboembolism secondary to COVID-19 has become a global
concern, with several surveys reporting increased mortality rates. Thrombogenic potential of …

A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis

F Marongiu, MF Ruberto, S Marongiu… - Clinical and …, 2023 - Springer
Systemic sclerosis is a multisystem connective tissue disease, characterized by endothelial
autoimmune activation, along with tissue and vascular fibrosis leading to vasculopathy and …

Ошибки диагностики и лечения тромбоэмболии легочной артерии

АП Медведев, СА Федоров, НА Трофимов… - Кардиология и …, 2021 - elibrary.ru
Тромбоэмболия легочной артерии (ТЭЛА) является крайне тяжелым заболеванием,
определяющим высокие показатели летальности населения индустриально развитых …

An update on applications and limitations of direct oral anticoagulants

S Wei, A Sawhney, H Khandait, A Meda… - The Egyptian Journal of …, 2023 - Springer
A major advancement in the field of medicine has been the introduction and usage of direct
oral anticoagulants (DOACs) such as dabigatran (Pradaxa), apixaban (Eliquis), and …

Is anticoagulative therapy in systemic sclerosis to be reconsidered?

F Marongiu, MF Ruberto… - Journal of Scleroderma …, 2024 - journals.sagepub.com
Systemic sclerosis is a rare disease with a high mortality rate. It is a multisystem connective
tissue disease due to endothelial autoimmune activation along with tissue and vascular …

Efficacy and safety of fondaparinux in preventing venous thromboembolism in Chinese cancer patients: a single-arm, multicenter, retrospective study

L Wang, Z Su, C Xie, R Li, W Pan, L Xu, F Chen… - Frontiers in …, 2023 - frontiersin.org
Objective Fondaparinux is a synthetic anticoagulant for the prevention of venous
thromboembolism (VTE), and its administration in Chinese cancer patients is rarely reported …

Differential Approach to Surgical and Endovascular Treatments of Pulmonary Thromboembolism in Patients with Neurological and Neurosurgical Problems

SA Fedorov, AP Medvedev… - IP Pavlov Russian …, 2022 - journals.eco-vector.com
INTRODUCTION: Pulmonary embolism (PE) is one of the most threatening complications in
patients with neurological and neurosurgical problems. The high epidemiological threshold …

[HTML][HTML] Дифференцированный подход к хирургическому и эндоваскулярному лечению тромбоэмболии легочной артерии в группе пациентов …

СА Федоров, АП Медведев… - … имени академика ИП …, 2022 - cyberleninka.ru
Введение. Тромбоэмболия легочной артерии (ТЭЛА) является одним из наиболее
грозных осложнений в структуре пациентов неврологического и нейрохирургического …

Currently available drugs for the treatment of Coronavirus-2

T Anbarasan, G Sahu, A Goyal - … Designing to Mitigate SARS-CoV-2 …, 2022 - Elsevier
Abstract The Coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe
acute respiratory syndrome Coronavirus 2 (SARS CoV-2) has created a never-before-seen …

Aktuelle Aspekte und Strategien zum Einsatz oraler Antikoagulantien und Plättchenfunktionshemmer in der Praxis

C Sucker, T Dörner - Aktuelle Rheumatologie, 2022 - thieme-connect.com
Aufgrund erhöhter venöser und arterieller Risiken und Begleiterkrankungen bei entzündlich-
rheumatischen Erkrankungen sind die Grundprinzipien der adäquaten medikamentösen …